The Director of Clinical & Scientific Affairs, Derma serves as the lead clinical testing expert to support product safety and advertising claims (Clinical Affairs) on all Derma brands, as well as a scientific liaison to the various business units, to consumers, and to scientific and medical professionals outside of the company (Scientific Affairs).

Reporting to the Head of Clinical & Scientific Affairs, this role oversees a team of three responsible for all launch and post-launch clinical testing and claim-support activities.

The position acts as a strategic advisor to local and HQ teams on product concepts to navigate US regulatory challenges and makes recommendations on risk assessment and mitigation. The Director of Clinical & Scientific Affairs Derma assesses new product and category opportunities and advises on the scientific strategic approach and represents and coordinates the scientific support in the case of legal challenges. He/she enhances the trust and credibility of the products and Derma brands by developing relationships with Key Opinion Leaders, by demonstrating knowledge and competency in the skin care category, and by sharing Beiersdorf's scientific knowledge and research capabilities through scientific presentations and publications.

This hybrid position requires three days per week onsite at the U.S. Innovation Center in Florham Park, NJ, with periodic travel to Stamford, CT, and up to 30% domestic and international travel, including occasional evenings and weekends for critical meetings and conferences.

Responsibilities:

• Evaluate, advise, and influence Brand teams and international partners on new product opportunities and Derma brand expansion categories in the US
• Assess global claims and scientific support and propose US compliant modifications of product positioning and claims concepts for new launches
• Develop and oversee safety and efficacy test plan, and claims substantiation strategy for Consumer and Medical communications
• Advise HQ R&D on US market, scientific and regulatory dynamics (in partnership with the US Regulatory functions) that impact the current and future pipeline
• Function as a key strategic partner in annual Dermatology Advisory Board meetings
• Advise senior management on risk assessment and specific mitigation strategies to protect the US business
• Innovate and propose new testing methods to expand product testing capabilities and tools outside of today’s CRO-localized testing methodologies
• Presents and train medical audiences and KOL Speakers Bureau participants (including Dermatologists, Physicians Assistants, Nurse Practitioners) on Derma product science and clinical efficacy data